-1 - Hematopathology WHO on Hematopoietic/Lymphoid Tissues

---

RSS

Occurs weekly every Monday, Tuesday, and Thursday starting on 1/3/2022 at 9:00 AM
Monday, January 3, 2022, 9:00 AM - 10:00 AM, Virtual, HOUSTON, TX


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours), ABPath MOC Part II (1.00 hours)

This series will discuss the changes in the World Health Organization (WHO) classification of hematological malignancies and how to implement these changes into practice. 

1. Understand and apply WHO Classification to patient specimens.
2. Apply ancillary techniques and integrate with morphologic findings of patient specimen; thereby, modifying diagnosis and direct therapeutic decisions.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
5/23/2022 9:00:00 AM	Hematopathology WHO on Hematopoietic/Lymphoid Tissues Diagnostic Challenges And Updates In Chronic Lymphoproliferative Disorder Of NK Cells - 5/23/2022 5/23/2022 9:00:00 AM 5/23/2022 10:00:00 AM 11 Virtual False MM/DD/YYYY	Hematopathology WHO on Hematopoietic/Lymphoid Tissues Diagnostic Challenges And Updates In Chronic Lymphoproliferative Disorder Of NK Cells - 5/23/2022 This series will discuss the changes in the World Health Organization (WHO) classification of hematological malignancies and how to implement these changes into practice.  Objective(s): 1 Understand and apply WHO Classification to patient specimens. 2 Apply ancillary techniques and integrate with morphologic findings of patient specimen; thereby, modifying diagnosis and direct therapeutic decisions. Location: Virtual Specialties: Other Faculty Disclosures: Min Shi, MD, PhD (Nothing to disclose - 05/09/2022) Download Handout Location: Virtual
5/26/2022 9:00:00 AM	Hematopathology WHO on Hematopoietic/Lymphoid Tissues B--ALL with recurrent translocations (part II) - 5/26/2022 5/26/2022 9:00:00 AM 5/26/2022 10:00:00 AM 11 Virtual False MM/DD/YYYY	Hematopathology WHO on Hematopoietic/Lymphoid Tissues B--ALL with recurrent translocations (part II) - 5/26/2022 This series will discuss the changes in the World Health Organization (WHO) classification of hematological malignancies and how to implement these changes into practice.  Objective(s): 1 Understand and apply WHO Classification to patient specimens. 2 Apply ancillary techniques and integrate with morphologic findings of patient specimen; thereby, modifying diagnosis and direct therapeutic decisions. Location: Virtual Specialties: Other Faculty Disclosures: Fnu Aakash, MBBS,MD (Nothing to disclose - 09/27/2021) Download Handout Location: Virtual